tetano
Editor, Senior Moderator
Int J Clin Exp Pathol. 2012;5(8):787-95. Epub 2012 Oct 1.
Emergence of HA mutants during influenza virus pneumonia.
Manríquez ME, Makino A, Tanaka M, Abe Y, Yoshida H, Morioka I, Arakawa S, Takeshima Y, Iwata K, Takasaki J, Manabe T, Nakaya T, Nakamura S, Iglesias AL, Rossales RM, Mirabal EP, Ito T, Kitazawa T, Oka T, Yamashita M, Kudo K, Shinya K.
Source
National Institute of Respiratory Diseases Mexico City, Mexico.
Abstract
During the influenza pandemic of 2009, the number of viral pneumonia cases showed a marked increase in comparison with seasonal influenza viruses. Mutations at amino acid 222 (D222G mutations) in the virus hemagglutinin (HA) molecule, known to alter the receptor-recognition properties of the virus, were detected in a number of the more severely-affected patients in the early phases of the pandemic. To understand the background for the emergence of the mutant amino acid D222G in human lungs, we conducted histological examinations on lung specimens of patients from Mexico who had succumbed in the pandemic. Prominent regenerative and hyperplastic changes in the alveolar type II pneumocytes, which express avian-type sialoglycan receptors in the respiratory tract of severely affected individuals, were observed in the Mexican patients. An infection model utilizing guinea pigs, which was chosen in order to best simulate the sialic acid distribution of severe pneumonia in human patients, demonstrated an increase of D222G mutants and a delay in the diminution of mutants in the lower respiratory tract in comparison to the upper respiratory tract. Our data suggests that the predominance of avian-type sialoglycan receptors in the pneumonic lungs may contribute to the emergence of viral HA mutants. This data comprehensively illustrates the mechanisms for the emergence of mutants in the clinical samples.
PMID:
23071861
[PubMed - in process]
PMCID:
PMC3466977
Free PMC Article
http://www.ncbi.nlm.nih.gov/pubmed/23071861
Emergence of HA mutants during influenza virus pneumonia.
Manríquez ME, Makino A, Tanaka M, Abe Y, Yoshida H, Morioka I, Arakawa S, Takeshima Y, Iwata K, Takasaki J, Manabe T, Nakaya T, Nakamura S, Iglesias AL, Rossales RM, Mirabal EP, Ito T, Kitazawa T, Oka T, Yamashita M, Kudo K, Shinya K.
Source
National Institute of Respiratory Diseases Mexico City, Mexico.
Abstract
During the influenza pandemic of 2009, the number of viral pneumonia cases showed a marked increase in comparison with seasonal influenza viruses. Mutations at amino acid 222 (D222G mutations) in the virus hemagglutinin (HA) molecule, known to alter the receptor-recognition properties of the virus, were detected in a number of the more severely-affected patients in the early phases of the pandemic. To understand the background for the emergence of the mutant amino acid D222G in human lungs, we conducted histological examinations on lung specimens of patients from Mexico who had succumbed in the pandemic. Prominent regenerative and hyperplastic changes in the alveolar type II pneumocytes, which express avian-type sialoglycan receptors in the respiratory tract of severely affected individuals, were observed in the Mexican patients. An infection model utilizing guinea pigs, which was chosen in order to best simulate the sialic acid distribution of severe pneumonia in human patients, demonstrated an increase of D222G mutants and a delay in the diminution of mutants in the lower respiratory tract in comparison to the upper respiratory tract. Our data suggests that the predominance of avian-type sialoglycan receptors in the pneumonic lungs may contribute to the emergence of viral HA mutants. This data comprehensively illustrates the mechanisms for the emergence of mutants in the clinical samples.
PMID:
23071861
[PubMed - in process]
PMCID:
PMC3466977
Free PMC Article
http://www.ncbi.nlm.nih.gov/pubmed/23071861
Last edited by a moderator: